Sirtuins at the crossroads of stemness, aging, and cancer

Carol O'Callaghan1, Athanassios Vassilopoulos1,2

  • 1Laboratory for Molecular Cancer Biology, Department of Radiation Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Aging Cell
|October 11, 2017
PubMed

Insights

Sirtuins, key regulators of cellular processes, impact stem cell function, aging, and cancer. Understanding their roles in normal and cancer stem cells offers therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Gerontology

Background:

  • Sirtuins are stress-responsive proteins regulating cellular processes, lifespan, and tumor development.
  • Altered stem cell function is linked to aging and cancer.
  • Sirtuins' roles in stem cells may mediate their involvement in aging and cancer.

Purpose of the Study:

  • Investigate sirtuins' roles in various stem cell types (embryonic, hematopoietic, adult).
  • Examine sirtuin involvement in cell differentiation and stem cell maintenance pathways.
  • Clarify sirtuins' diverse functions in normal and cancer stem cells (CSCs).

Main Methods:

  • Literature review of existing research on sirtuins and stem cells.
  • Analysis of sirtuin family members' differential regulation of stem cells.
  • Exploration of sirtuin-driven signaling pathways in stem cell maintenance.

Main Results:

  • Sirtuins differentially regulate various stem cell types in a context-specific manner.
  • Sirtuins influence cell differentiation and signaling pathways crucial for stem cell maintenance.
  • Sirtuins exhibit diverse roles in cancer stem cells, dependent on tissue origin.

Conclusions:

  • Sirtuins are central to the interplay between stem cells, aging, and cancer.
  • Understanding sirtuin functions in stem cells is crucial for cancer and aging research.
  • Further research into sirtuins may reveal significant therapeutic potential for aging and cancer.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...